SCHEMBL6600560

SCHEMBL6600560

COc1c(OCCN2CCOCC2)cc(N)c(-c2ncnc(-n3c(Cl)nc4ccccc43)n2)c1OC

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.40
MKNK1 Q9BUB5 1/20 0.39
EGFR P00533 4/20 0.39
KDR P35968 3/20 0.39
FGFR1 P11362 1/20 0.39
FLT1 P17948 1/20 0.39
FLT4 P35916 1/20 0.39
ADCY10 Q96PN6 1/20 0.39
EPHA2 P29317 1/20 0.39
EPHB4 P54760 1/20 0.39
HTR2C P28335 1/20 0.39
HTR2B P41595 1/20 0.39
LMNA P02545 2/20 0.39
SRC P12931 1/20 0.39
ATM Q13315 1/20 0.38
PDPK1 O15530 1/20 0.38
SYK P43405 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6607258 0.94 SYK (0.43) PDE2AMKNK1EGFRKDRFGFR1
SCHEMBL6479597 0.81 KDR (0.57) EGFRKDRFGFR1FLT1FLT4
SCHEMBL6493240 0.77 KDR (0.56) EGFRKDRFGFR1FLT1FLT4
SCHEMBL14380859 0.68 KDR (0.51) MKNK1EGFRKDRSRC
SCHEMBL2011534 0.66 CYP2D6 (0.60) HTR2CHTR2BSYKTSHR
SCHEMBL4088385 0.66 SYK (0.59) KDREPHA2EPHB4HTR2CHTR2B
SCHEMBL2088116 0.65 SYK (0.65) HTR2CHTR2BSRCSYKTSHR
SCHEMBL21642597 0.63 KDR (0.56) EGFRKDRFGFR1FLT1FLT4
SCHEMBL6478952 0.63 KDR (0.74) EGFRKDRFGFR1FLT1EPHB4
SCHEMBL1853220 0.63 DRD1 (0.62) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1385833-A1 TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS Amgen Inc. (US) 2004-02-04 EP disclosed
WO-2002083654-A1 TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS AMGEN INC. (US) 2002-10-24 WO disclosed